No Effect of Genetic Polymorphisms on Cyclosporine Pharmacokinetics in Renal Transplant Recipients Based on Nonlinear Mixed Effects Modeling

2016 ◽  
Vol 16 (12) ◽  
pp. 12362-12368 ◽  
Author(s):  
Danying Li ◽  
Jianzhong Rui ◽  
Huaijun Zhu ◽  
Guohua Zhou ◽  
Weihong Ge ◽  
...  
2015 ◽  
Vol 60 (1) ◽  
pp. 617-620 ◽  
Author(s):  
Stefanie Hennig ◽  
Suhashni Naiker ◽  
Tarylee Reddy ◽  
Deirdre Egan ◽  
Tracy Kellerman ◽  
...  

ABSTRACTRifabutin, used to treat HIV-infected tuberculosis, shows highly variable drug exposure, complicating dosing. Effects ofSLCO1B1polymorphisms on rifabutin pharmacokinetics were investigated in 35 African HIV-infected tuberculosis patients after multiple doses. Nonlinear mixed-effects modeling found that influential covariates for the pharmacokinetics were weight, sex, and a 30% increased bioavailability among heterozygous carriers ofSLCO1B1rs1104581 (previously associated with low rifampin concentrations). Larger studies are needed to understand the complex interactions of host genetics in HIV-infected tuberculosis patients. (This study has been registered at ClinicalTrials.gov under registration no. NCT00640887.)


2009 ◽  
Vol 23 (4) ◽  
pp. 490-498 ◽  
Author(s):  
Ranjana Singh ◽  
Parmeet K. Manchanda ◽  
Pravin Kesarwani ◽  
Aneesh Srivastava ◽  
Rama D. Mittal

2013 ◽  
Vol 92 (7) ◽  
pp. 1942-1948 ◽  
Author(s):  
Emre Karaman ◽  
Dogan Narinc ◽  
Mehmet Ziya Firat ◽  
Tulin Aksoy

Sign in / Sign up

Export Citation Format

Share Document